DRKS00003069招募中不适用
on-interventional study for recording the treatment and the influence on the treatment-specific quality of life with patients with hormone-refractory prostate cancer under a Docetaxel (Eurotere®) containing chemotherapy. - ProQoLTere
apharm GmbH0 个研究点目标入组 500 人开始时间: 2011年5月2日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 500
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 99 Years（—）
- 性别
- Male
入选标准
- •Histologically confirmed hormone-refractory prostate cancer.
- •Signed patient informed consent form.
排除标准
- •Other malignant diseases in the past 5 years,
- •Lack of compliance.
研究者
相似试验
进行中（未招募）
不适用
Collection of data on the use of a VWF/FVIII concentrate (wilate®) in all clinical applications in von Willebrand diseaseISRCTN11568655Octapharma GmbH120
进行中（未招募）
不适用
on-interventional study on management of treatment and safety in patients with secondary immunodeficiency due to haematological malignancies treated with Ig Vena according to the approved therapeutic indicationsD84.9C90.0C91.1Immunodeficiency, unspecifiedChronic lymphocytic leukaemia of B-cell typeMultiple myelomaDRKS00016556Kedrion S.p.A.25
已完成
不适用
on-interventional retrospective study to evaluate the menstrual cycle profiles and quality of life of women after the use of the new vaginal ring GinoRing® delivering 0.120mg etonogestrel and 0.015mg ethinylestradiol per dayN92.0Excessive and frequent menstruation with regular cycleDRKS00014982Exeltis Germany GmbH103
招募中
1 期
An Interventional and Translational Study investigating Sotorasib in Previously Treated Locally Advanced or Metastatic NSCLC Subjects With Mutated KRAS p.G12C (CODEBREAK)locally-advanced and unresectable or metastatic NSCLC with KRAS G12CMedDRA version: 21.1Level: PTClassification code: 10061873Term: Non-small cell lung cancer Class: 100000004864MedDRA version: 25.1Level: LLTClassification code: 10069759Term: KRAS mutation Class: 10018065CTIS2024-510837-16-00Institut Gustave Roussy40
进行中（未招募）
1 期
An Interventional and Translational Study investigating Sotorasib in Previously Treated Locally Advanced or Metastatic non-small-cell lung cancerocally-advanced and unresectable or metastatic non-small-cell lung cancer with KRAS G12C mutationEUCTR2021-006958-31-FRGustave Roussy40